Contingent Liabilities and Commitments (Details) € in Thousands |
12 Months Ended |
|---|---|
|
Dec. 31, 2023
EUR (€)
| |
| Contingent Liabilities and Commitments (Details) [Line Items] | |
| Commission income expense | € 25 |
| Annual royalties | € 10 |
| Patent agreement, description | Royalties in a total amount of up to €850 thousand based on certain progress milestones in the license stages of the products, which are the subject of the patent under the agreement, as follows: (i) €50 thousand upon initiation of Phase I studies; (ii) €100 thousand upon initiation of Phase II studies; (iii) €200 thousand upon initiation of Phase III studies; and (iv) €500 thousand upon marketing approval by any regulatory authority. |
| Royalties in a total amount | € 850 |
| Royalty payments, percentage | 10.00% |
| Minimum [Member] | |
| Contingent Liabilities and Commitments (Details) [Line Items] | |
| Percentage of net sales | 2.00% |
| Maximum [Member] | |
| Contingent Liabilities and Commitments (Details) [Line Items] | |
| Percentage of net sales | (3.00%) |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The description of patent agreement. No definition available.
|
| X | ||||||||||
- Definition The percentage of net sales. No definition available.
|
| X | ||||||||||
- Definition The royalty payment in percentage. No definition available.
|
| X | ||||||||||
- Definition The amount paid to music publishers, record producers, songwriters, or other artists in advance of their earning royalties from record or music sales. Such an amount is based on contractual terms and is generally nonrefundable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of fees incurred for commissions on mutual funds and insurance products. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|